Farkas, A. M., Baranyi, U., Bohmig, G. A., Unger, L., Hopf, S., Wahrmann, M., Regele, H., Mahr, B., Schwarz, C., Hock, K., Pilat, N., Kristo, I., Mraz, J., Lupinek, C, Thalhamer, J., Bond, G., Kuessel, L., Wlodek, E., Martin, J., Clatworthy, M., Pettigrew, G., Valenta, R. and Wekerle, T. 2019. Allograft rejection is associated with development of functional IgE specific for donor MHC antigens. J Allergy Clin Immunol;143(1):335-45 e12; 10.1016/j.jaci.2018.06.034
Granofszky, N., Farkas, A. M., Muckenhuber, M., Mahr, B., Unger, L., Maschke, S., Pilat, N., Holly, R., Wiletel, M., Regele, H. and Wekerle, T. 2017. Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model. Front Immunol;8:821; 10.3389/fimmu.2017.00821
Duran-Struuck, R., Sondermeijer, H. P., Buhler, L., Alonso-Guallart, P., Zitsman, J., Kato, Y., Wu, A., McMurchy, A. N., Woodland, D., Griesemer, A., Martinez, M., Boskovic, S., Kawai, T., Cosimi, A. B., Wuu, C. S., Slate, A., Mapara, M. Y., Baker, S., Tokarz, R., D'Agati, V., Hammer, S., Pereira, M., Lipkin, W. I., Wekerle, T., Levings, M. K. and Sykes, M. 2017. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques. Transplantation 101(2):274-83; 10.1097/TP.0000000000001559
Baranyi U., Farkas A., Hock K., Mahr B., Linhart B., Gattringer M., Focke-Tejkl M., Petersen A., Wrba F., Rulicke T., Valenta R., Wekerle T. 2016. Cell therapy for prophylactic tolerance in IgE-mediated allergy. EBioMedicine 7: 230-9
Pilat, N., Baranyi, U., Klaus, C., Jaeckel, E., Mpofu, N., Wrba, F., Golshayan, D., Muehlbacher, F., and T. Wekerle. 2010. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant 10:751-62.
Vincenti, F., Larsen, C., Durrbach, A., Wekerle, T., Nashan, B., Blancho, G., Lang, P., Grinyo, J., Halloran, P. F., Solez, K., Hagerty, D., Levy, E., Zhou, W., Natarajan, K., and Charpentier, B. for the belatacept study group. 2005. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353:770-81.
Blaha, P., Bigenzahn, S., Koporc, Z., Schmid, M., Langer, F., Selzer, E., Bergmeister, H., Wrba, F., Kurtz, J., Kiss, C., Roth, E., Muehlbacher, F., Sykes, M., and T. Wekerle. 2003. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101:2886-93.
Wekerle, T., Kurtz, J., Ito, H., Ronquillo, J. V., Dong, V., Zhao, G., Shaffer, J., Sayegh, M. H., and Sykes, M. 2000. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med 6:464-9.
Wekerle, T., Sayegh, M. H., Hill, J., Zhao, Y., Chandraker, A., Swenson, K. G., Zhao, G., and Sykes, M. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187:2037-44.
